CB1R is strongly upregulated in hepatocytes and during hepatic steatosis, inflammation, and liver fibrosis, whereas CB2R expression protects against liver injury because of its antifibrogenic and anti-inflammatory properties [18]. This evidence concerns the gene CNR1 and Hepatic steatosis.